Project Description:  Two-story R&D building

Building Size: ± 100,000 square feet

Built by:  Stanford Real Estate 

Tenant:  Jazz Pharmaceuticals

Expected Completion:  February 2018

This project is a redevelopment of an existing R&D building, formerly occupied by Lockheed, that was approaching the end of its useful life. Stanford Real Estate began the redevelopment process of the property in 2014.

In January 2015, Jazz Pharmaceuticals, a Dublin, Ireland based biopharmaceutical company, leased the upcoming building. Jazz develops and commercializes pharmaceutical products to address medical needs in the therapeutic areas of narcolepsy, oncology, pain and psychiatry. Tenants in the Stanford Research Park since 2004, Jazz will consolidate two of its locations under one roof.